These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 16772001

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
    Nzila A.
    Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
    [Abstract] [Full Text] [Related]

  • 4. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R, Basco LK.
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of resistance of malaria parasites to antifolates.
    Gregson A, Plowe CV.
    Pharmacol Rev; 2005 Mar; 57(1):117-45. PubMed ID: 15734729
    [Abstract] [Full Text] [Related]

  • 6. The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.
    Nzila A.
    J Antimicrob Chemother; 2006 Jun; 57(6):1043-54. PubMed ID: 16617066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M, Barreto Miranda I, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Löscher T.
    Malar J; 2007 Jan 15; 6():2. PubMed ID: 17224049
    [Abstract] [Full Text] [Related]

  • 9. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ.
    J Infect Dis; 2008 Jun 01; 197(11):1605-13. PubMed ID: 18471066
    [Abstract] [Full Text] [Related]

  • 10. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
    Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Khalil IF, Theander TG, Lemnge MM, Bygbjerg IC.
    Am J Trop Med Hyg; 2009 Apr 01; 80(4):523-7. PubMed ID: 19346369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Folate metabolism in malaria.
    Ferone R.
    Bull World Health Organ; 1977 Apr 01; 55(2-3):291-8. PubMed ID: 338184
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
    Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F.
    Trop Med Int Health; 2007 Oct 01; 12(10):1164-71. PubMed ID: 17956498
    [Abstract] [Full Text] [Related]

  • 15. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE, Alifrangis M, Khalil IF, Bygbjerg IC, Masuadi EM, Elbashir MI, Giha HA.
    Malar J; 2007 Aug 08; 6():108. PubMed ID: 17686173
    [Abstract] [Full Text] [Related]

  • 16. Drug resistance hampers our capacity to roll back malaria.
    Olliaro P.
    Clin Infect Dis; 2005 Aug 15; 41 Suppl 4():S247-57. PubMed ID: 16032560
    [Abstract] [Full Text] [Related]

  • 17. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Am J Trop Med Hyg; 2006 Jul 15; 75(1):155-61. PubMed ID: 16837724
    [Abstract] [Full Text] [Related]

  • 18. [Antimalarial drug resistance].
    Le Bras J, Musset L, Clain J.
    Med Mal Infect; 2006 Aug 15; 36(8):401-5. PubMed ID: 16854546
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
    Babiker HA, Hastings IM, Swedberg G.
    Expert Rev Anti Infect Ther; 2009 Jun 15; 7(5):581-93. PubMed ID: 19485798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.